FDA批准Medtronic的新Parkinson装置 实时将脑刺激个性化 FDA approves Medtronic's new Parkinson's device that personalizes brain stimulation in real-time.

美国食品和药物管理局批准了Medtronic的BrainSense自适应DBS系统, The FDA has approved Medtronic's BrainSense Adaptive DBS system, designed to manage Parkinson's symptoms by providing personalized, real-time brain stimulation. 该系统根据个体脑活动调整治疗方法,与传统方法相比,初步方案规划的临床访问需求减少了85%。 This system adjusts therapy based on individual brain activity, reducing the need for clinic visits by 85% for initial programming compared to traditional methods. 它旨在提供更加平衡的治疗,适应每个病人的具体情况和需要。 It aims to offer more balanced treatment, adapting to each patient's specific condition and needs.